Home > News > Latest > CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors

CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors

CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various healthcare applications, today announces the appointment of Dr. Alan E. Einstein to its board of directors.